Genetic Mutation Assay in Ovarian Cancer Patient Danastri Tiara Cintantya1, and Willy Sandhika2,3* Abstract Ovarian cancer is the third most common cases of cancer among Indonesian women. It has a poor prognosis with a moderate to low 5-year survival rate with conventional therapy. Targeted therapies, immunotherapies, and novel treatment approaches